25698-27-5

Usage

Uses

Used in Pharmaceutical Industry:
(R)-4-hydroxyphenylglycine is used as a key intermediate in the production of antibiotics, such as vancomycin, for its role in the synthesis of these essential medications.
Used in Agrochemical Industry:
(R)-4-hydroxyphenylglycine is used as a building block in the synthesis of agrochemicals, contributing to the development of effective products for agricultural applications.
Used in Drug Development:
(R)-4-hydroxyphenylglycine is used as a valuable component in the development of new drugs and bioactive molecules, owing to its unique chemical structure and properties.
Used in Treatment of Various Diseases and Conditions:
(R)-4-hydroxyphenylglycine is used for its potential applications in the treatment of various diseases and conditions, due to its biological activity.

InChI:InChI=1/C8H9NO3/c10-7-3-1-2-6(4-7)9-5-8(11)12/h1-4,9-10H,5H2,(H,11,12)

Downstream Products

• 139377-38-1 D-3-hydroxyphenylglycine ethyl ester 
• 130697-97-1 (R)-tert-Butoxycarbonylamino-{3-[5-((2R,5R)-5-isopropyl-3,6-dimethoxy-2,5-dihydro-pyrazin-2-yl)-3-methoxy-2-methyl-phenoxy]-phenyl}-acetic acid methyl ester 
• 130633-33-9 (R)-tert-Butoxycarbonylamino-{3-[5-((2S,5R)-5-isopropyl-3,6-dimethoxy-2,5-dihydro-pyrazin-2-yl)-3-methoxy-2-methyl-phenoxy]-phenyl}-acetic acid methyl ester 
• 130633-34-0 (S)-Amino-{3-[3-((R)-tert-butoxycarbonylamino-methoxycarbonyl-methyl)-phenoxy]-5-methoxy-4-methyl-phenyl}-acetic acid methyl ester 
• 130633-35-1 (S)-Amino-{3-[3-((R)-amino-methoxycarbonyl-methyl)-phenoxy]-5-methoxy-4-methyl-phenyl}-acetic acid methyl ester 
• 130633-32-8 methyl phenylglycinate 
• 136057-28-8 (R)-4-{3-[4-((R)-2-[(R)-2-Benzyloxycarbonylamino-2-(4-hydroxy-phenyl)-acetylamino]-2-{[(S)-tert-butoxycarbonyl-(4-tert-butoxy-phenyl)-methyl]-carbamoyl}-ethyl)-phenoxy]-phenyl}-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 136057-27-7 (R)-4-{3-[4-((R)-2-Azido-2-{[(S)-tert-butoxycarbonyl-(4-tert-butoxy-phenyl)-methyl]-carbamoyl}-ethyl)-phenoxy]-phenyl}-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 136057-23-3 (R)-4-(3-{4-[3-((R)-4-Benzyl-2-oxo-oxazolidin-3-yl)-3-oxo-propyl]-phenoxy}-phenyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 136057-31-3 (3-{4-[3-((R)-1-Amino-2-hydroxy-ethyl)-phenoxy]-phenyl}-propionylamino)-acetic acid; hydrochloride 
• 136057-30-2 (R)-4-(3-{4-[2-(tert-Butoxycarbonylmethyl-carbamoyl)-ethyl]-phenoxy}-phenyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 136057-21-1 (R)-4-{3-[4-(2-Methoxycarbonyl-ethyl)-phenoxy]-phenyl}-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 136057-20-0 (R)-4-{3-[4-((E)-2-Methoxycarbonyl-vinyl)-phenoxy]-phenyl}-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 136057-22-2 (R)-4-{3-[4-(2-Carboxy-ethyl)-phenoxy]-phenyl}-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

Production of ring-substituted D-phenylglycines by microbial or enzymatic hydrolysis/deracemisation of the corresponding DL-hydantoins

A series of 17 ring-mono and -disubstituted D-phenylglycine derivatives was prepared in high enantiomeric purity by enzymatic hydrolysis and deracemisation of the corresponding DL-hydantoins, using D-hydantoinase activities of microorganisms or purified enzymes, followed by diazotation of the resulting N-carbamyl-D-amino acids. No significant L-hydantoinase activity was found to produce the corresponding L-enantiomers.